NCT06951581View on ClinicalTrials.gov

Impact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients.

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

July 15, 2024

Study Completion Date

July 30, 2024

Conditions
Metabolic EffectsImmunosuppressive AgentsAdverse EventsImunological EffectsInflamatory MarkersMetabolomic EffectsRenal Function
Interventions
DIETARY_SUPPLEMENT

Short Chain Fatty Acid

Participants in this arm will receive an oral formulation of short-chain fatty acids (SCFAs) daily for 12 weeks. SCFAs are administered as a dietary supplement to investigate their potential impact on the systemic and urinary metabolome in kidney transplant recipients.

DIETARY_SUPPLEMENT

Placebo Capsule(s)

Oral capsules with sacharosa (200 mg) matching SCFA appearance, administered once a day.

Trial Locations (1)

03601

University Hospital Martin, Martin

All Listed Sponsors
collaborator

Comenius University

OTHER

lead

University Hospital, Martin

OTHER

NCT06951581 - Impact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients. | Biotech Hunter | Biotech Hunter